Pictet Asset Management (Switzerland)’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $21.4M | Buy |
1,517,123
+74,096
| +5% | +$1.04M | 0.03% | 446 |
|
|
2023
Q1 | $15.5M | Buy |
1,443,027
+208,834
| +17% | +$2.25M | 0.02% | 522 |
|
|
2022
Q4 | $18.5M | Sell |
1,234,193
-1,803,668
| -59% | -$27M | 0.03% | 459 |
|
|
2022
Q3 | $39M | Sell |
3,037,861
-493,941
| -14% | -$6.34M | 0.06% | 310 |
|
|
2022
Q2 | $34.2M | Hold |
3,531,802
| – | – | 0.05% | 348 |
|
|
2022
Q1 | $35.1M | Sell |
3,531,802
-16,847
| -0.5% | -$167K | 0.04% | 378 |
|
|
2021
Q4 | $41.8M | Buy |
3,548,649
+213,744
| +6% | +$2.52M | 0.04% | 377 |
|
|
2021
Q3 | $38M | Buy |
+3,334,905
| New | +$38M | 0.04% | 387 |
|